These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38845272)

  • 1. Knowledge of biological therapy for patients with immune-mediated diseases. BIOINFO Study.
    Seguí-Solanes C; Estrada L; Ramírez Herráiz E; Ruiz-García S; Palanques-Pastor T; Merino Bohórquez V; Capilla Montes C; Borras-Blasco J
    Farm Hosp; 2024 Jun; ():. PubMed ID: 38845272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic.
    López Sánchez P; Palanques Pastor T; Ibarra Barrueta O; Ramírez Herráiz E; Casellas Gibert M; Monte Boquet E
    Farm Hosp; 2024 Jun; ():. PubMed ID: 38906719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey.
    Frantzen L; Cohen JD; Tropé S; Beck M; Munos A; Sittler MA; Diebolt R; Metzler I; Sordet C
    Joint Bone Spine; 2019 Jul; 86(4):491-496. PubMed ID: 30659920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Knowledge about Biosimilars in Primary Care: a study by the Spanish Society of Primary Care Physicians (SEMERGEN)].
    Micó-Pérez RM; Payares-Herrera C; Palomo-Jiménez PI; Sánchez-Fierro J; Avendaño-Solá C; Llisterri-Caro JL
    Semergen; 2018 Sep; 44(6):380-388. PubMed ID: 29459003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for Overcoming Barriers to Adopting Biosimilars and Achieving Goals of the Biologics Price Competition and Innovation Act: A Survey of Managed Care and Specialty Pharmacy Professionals.
    Greene L; Singh RM; Carden MJ; Pardo CO; Lichtenstein GR
    J Manag Care Spec Pharm; 2019 Aug; 25(8):904-912. PubMed ID: 31007119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
    Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
    J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An online survey among US patients with immune-mediated conditions: Attitudes about biosimilars.
    Gibofsky A; Jacobson G; Franklin A; O'Hara-Levi S; Peyrin-Biroulet L; McGrath M; McCabe D
    J Manag Care Spec Pharm; 2023 Apr; 29(4):343-349. PubMed ID: 36989450
    [No Abstract]   [Full Text] [Related]  

  • 10. Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?
    Müskens WD; Rongen-van Dartel SAA; van Riel PLCM; Adang EMM
    J Rheumatol; 2021 Dec; 48(12):1803-1809. PubMed ID: 33132223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.
    Chapman SR; Fitzpatrick RW; Aladul MI
    BMJ Open; 2017 Jun; 7(6):e016730. PubMed ID: 28637743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosimilars and access to biologic therapy in immune-mediated diseases.
    Vázquez-Sánchez R; Navarro-Dávila M; Herráiz ER; Merino-Bohórquez V; Borrás-Blasco J; Onteniente-González A; Iglesias-Lambarri A; Negro-Vega E
    Expert Opin Biol Ther; 2024 May; ():1-7. PubMed ID: 38698351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives toward biosimilars among oncologists: A Malaysian survey.
    Chong SC; Rajah R; Chow PL; Tan HC; Chong CM; Khor KY; Lee WP; Tan WY
    J Oncol Pharm Pract; 2022 Jun; ():10781552221104773. PubMed ID: 35698761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient attitudes and understanding about biosimilars: an international cross-sectional survey.
    Jacobs I; Singh E; Sewell KL; Al-Sabbagh A; Shane LG
    Patient Prefer Adherence; 2016; 10():937-48. PubMed ID: 27307714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey.
    Kolbe AR; Kearsley A; Merchant L; Temkin E; Patel A; Xu J; Jessup A
    BioDrugs; 2021 May; 35(3):363-372. PubMed ID: 33826078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
    Lightner AL; Grass F; Alsughayer AM; Harmsen WS; Petersen M; Loftus EV
    Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
    Lindström U; Glintborg B; Di Giuseppe D; Nordström D; Aarrestad Provan S; Gudbjornsson B; Askling J; Lund Hetland M; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
    RMD Open; 2019; 5(2):e001079. PubMed ID: 31749988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Polish Task Force position statement on safety of biologic treatment with monoclonal antibodies and soluble receptors].
    Jahnz-Rozyk K; Wiesik-Szewczyk E;
    Pol Merkur Lekarski; 2014 Jul; 37(217):5-9. PubMed ID: 25154192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosimilars for Pediatric Patients With Inflammatory Bowel Disease: Pediatric Gastroenterology Clinical Practice Survey.
    Maltz RM; McClinchie MG; Boyle BM; McNicol M; Morris GA; Crawford EC; Moses J; Kim SC
    J Pediatr Gastroenterol Nutr; 2023 May; 76(5):616-621. PubMed ID: 36827968
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.